References
- Iung B, Cachier A, Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26, 2714–2720 (2005).
- Leon MB, Smith CR, Mack M et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597–607 (2010).
- Athappan G, Patvardhan E, Tuzcu EM et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J. Am. Coll. Cardiol. 61(15), 1585–1595 (2013).
- Ewe SH, Ng AC, Schuijf JD et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am. J. Cardiol. 108, 1470–1477 (2011).
- Sherif A, Abdel-Wahab M, Stocker B et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValvebioprosthesis. J. Am. Coll. Cardiol. 56(20), 1623–1629 (2010).
- Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123, 299–308 (2011).
- Moat NE, Ludman P, Belder MA et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J. Am. Coll. Cardiol. 58, 2130–2138 (2011).
- Gilard M, Eltchaninoff H, Iung B et al. FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 366(18), 1705–1715 (2012).
- Kapadia SR. Three-year outcomes of transcatheter aortic valve replacement in ‘inoperable’ patients with severe aortic stenosis: the PARTNER trial. Presented at: Transcatheter Cardiovascular Therapeutics. Miami, FL, USA, October 2012.
- Toggweiler S, Humphries KH, Lee M et al. 5-year outcome after transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 61(4), 413–419 (2013).
- Messika-Zeitoun D, Serfaty JM, Brochet E et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 55, 186–194 (2010).
- Takagi K, Latib A, Al-Lamee R et al. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after corevalve implantation and the impact of postdilatation. Catheter. Cardiovasc. Interv. 78, 432–443 (2011).
- Colombo A. Results from the DISCOVER trial. Presented at: EuroPCR. Paris, FRA, May 2013.
- Meredith I, Worthley S, Whitbourn R et al. First report of one-year outcomes of the REPRISE I feasibility study of the repositionable Lotus Aortic Valve Replacement System. Presented at: EuroPCR. FRA, Paris (2013).
- Meredith I. Results from REPRISE II study. Presented at: EuroPCR. FRA, Paris (2013).
- Willson AB, Rodès-Cabau J, Wood DA et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J. Am. Coll. Cardiol. 160(7), 581–586 (2012).
- Binder RK, Schäfer U, Kuck KH et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc. Interv. 6(3), 301–307 (2013).
- Treede H. Results from the JenaValve. Second generation transcatheter aortic valve implantation system. Presented at: Transcatheter Cardiovascular Therapeutics. San Francisco, CA, USA (2011).
- Grube E. Next generation TAVI systems. Presented at: Transcatheter Cardiovascular Therapeutics. Miami, FL, USA (2012).
- Osnabrugge RL, Mylotte D, Head SJ et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modelling study. J. Am. Coll. Cardiol. doi:pii: S0735–1097(13)02079–2 (2013).